Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Apr 17, 2017 · 10-K · 107 days after period end · 0001144204-17-020754
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $71.00K | $863.00K | $872.00K | $0.00 |
| Net Income | -$30.71M | -$24.08M | -$42.69M | -$16.89M |
| EPS Diluted | — | -$0.27 | -$0.64 | — |
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2016 · filed Apr 17, 2017 · 107 d after period end
